John Quilter is vice president, global portfolio, ProActive Health, at Kerry. Quilter has over two decades’ experience in the agribusiness, food, beverage, nutrition, and education sectors. In his current role, he manages the Kerry ProActive Health business unit, which is responsible for Kerry’s ProActive Health portfolio. Made up of trusted, science-backed functional ingredients aligned with the greatest current wellness concerns, the portfolio is designed to help manufacturers meet the proactive health needs of consumers across the world. It includes BC30, a spore-forming probiotic that remains viable through most manufacturing processes and the journey to the gut; and Wellmune, a clinically supported proprietary baker’s yeast beta 1,3/1,6 glucan for food, beverage, and supplements. Clinically supported to help strengthen the immune system, it’s the only yeast beta-glucan ingredient supported by over a dozen published, peer-reviewed clinical studies.